These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Double-blind, placebo-controlled study of the long-term efficacy of carvedilol in patients with severe chronic heart failure. Krum H, Sackner-Bernstein JD, Goldsmith RL, Kukin ML, Schwartz B, Penn J, Medina N, Yushak M, Horn E, Katz SD. Circulation; 1995 Sep 15; 92(6):1499-506. PubMed ID: 7664433 [Abstract] [Full Text] [Related]
5. Carvedilol produces dose-related improvements in left ventricular function and survival in subjects with chronic heart failure. MOCHA Investigators. Bristow MR, Gilbert EM, Abraham WT, Adams KF, Fowler MB, Hershberger RE, Kubo SH, Narahara KA, Ingersoll H, Krueger S, Young S, Shusterman N. Circulation; 1996 Dec 01; 94(11):2807-16. PubMed ID: 8941106 [Abstract] [Full Text] [Related]
10. Effects of carvedilol in heart failure due to dilated cardiomyopathy. Results of a double-blind randomized placebo-controlled study (CARIBE study). Chizzola PR, Freitas HF, Caldas MA, da Costa JM, Meneghetti C, Marinho NV, Mansur AJ, Ramires JA, Bocchi EA. Arq Bras Cardiol; 2000 Mar 01; 74(3):233-42. PubMed ID: 10951826 [Abstract] [Full Text] [Related]
16. Beneficial effects of pentoxifylline in patients with idiopathic dilated cardiomyopathy treated with angiotensin-converting enzyme inhibitors and carvedilol: results of a randomized study. Skudicky D, Bergemann A, Sliwa K, Candy G, Sareli P. Circulation; 2001 Feb 27; 103(8):1083-8. PubMed ID: 11222470 [Abstract] [Full Text] [Related]
17. Carvedilol improves left ventricular function and symptoms in chronic heart failure: a double-blind randomized study. Olsen SL, Gilbert EM, Renlund DG, Taylor DO, Yanowitz FD, Bristow MR. J Am Coll Cardiol; 1995 May 27; 25(6):1225-31. PubMed ID: 7722114 [Abstract] [Full Text] [Related]
18. Randomised, placebo-controlled trial of carvedilol in patients with congestive heart failure due to ischaemic heart disease. Australia/New Zealand Heart Failure Research Collaborative Group. Lancet; 1997 Feb 08; 349(9049):375-80. PubMed ID: 9033462 [Abstract] [Full Text] [Related]